125 related articles for article (PubMed ID: 28164646)
1. Analysis of the Association between MDM4 rs4245739 Single Nucleotide Polymorphism and Breast Cancer Susceptibility.
Pedram N; Pouladi N; Feizi MA; Montazeri V; Sakhinia E; Estiar MA
Clin Lab; 2016 Jul; 62(7):1303-1308. PubMed ID: 28164646
[TBL] [Abstract][Full Text] [Related]
2. Lack of Associations of the MDM4 rs4245739 Polymorphism with Risk of Thyroid Cancer among Iranian-Azeri Patients: a Case-Control Study.
Mohammad Khanlou Z; Pouladi N; Hosseinpour Feizi M; Pedram N
Asian Pac J Cancer Prev; 2017 Apr; 18(4):1133-1138. PubMed ID: 28547953
[TBL] [Abstract][Full Text] [Related]
3. Functional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibility.
Liu J; Tang X; Li M; Lu C; Shi J; Zhou L; Yuan Q; Yang M
Breast Cancer Res Treat; 2013 Jul; 140(1):151-7. PubMed ID: 23793604
[TBL] [Abstract][Full Text] [Related]
4. The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.
Gansmo LB; Bjørnslett M; Halle MK; Salvesen HB; Dørum A; Birkeland E; Hveem K; Romundstad P; Vatten L; Lønning PE; Knappskog S
Tumour Biol; 2016 Aug; 37(8):10697-702. PubMed ID: 26867771
[TBL] [Abstract][Full Text] [Related]
5. MDM4 SNP34091 (rs4245739) and its effect on breast-, colon-, lung-, and prostate cancer risk.
Gansmo LB; Romundstad P; Birkeland E; Hveem K; Vatten L; Knappskog S; Lønning PE
Cancer Med; 2015 Dec; 4(12):1901-7. PubMed ID: 26471763
[TBL] [Abstract][Full Text] [Related]
6. Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.
Hashemi M; Sanaei S; Hashemi SM; Eskandari E; Bahari G
Clin Breast Cancer; 2018 Oct; 18(5):e883-e891. PubMed ID: 29439926
[TBL] [Abstract][Full Text] [Related]
7. A genetic variant within MDM4 3'UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer.
Zhang Y; Sturgis EM; Wei P; Liu H; Wang Z; Ma Y; Liu C; Gu KJ; Wei Q; Li G
Mol Carcinog; 2019 Dec; 58(12):2276-2285. PubMed ID: 31513313
[TBL] [Abstract][Full Text] [Related]
8. Association of a genetic variation in a miR-191 binding site in MDM4 with risk of esophageal squamous cell carcinoma.
Zhou L; Zhang X; Li Z; Zhou C; Li M; Tang X; Lu C; Li H; Yuan Q; Yang M
PLoS One; 2013; 8(5):e64331. PubMed ID: 23724042
[TBL] [Abstract][Full Text] [Related]
9. A Regulatory MDM4 Genetic Variant Locating in the Binding Sequence of Multiple MicroRNAs Contributes to Susceptibility of Small Cell Lung Cancer.
Gao F; Xiong X; Pan W; Yang X; Zhou C; Yuan Q; Zhou L; Yang M
PLoS One; 2015; 10(8):e0135647. PubMed ID: 26274820
[TBL] [Abstract][Full Text] [Related]
10. A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer.
Stegeman S; Moya L; Selth LA; Spurdle AB; Clements JA; Batra J
Endocr Relat Cancer; 2015 Apr; 22(2):265-76. PubMed ID: 25670033
[TBL] [Abstract][Full Text] [Related]
11. Variations within 3'-UTR of MDM4 gene contribute to clinical outcomes of advanced non-small cell lung cancer patients following platinum-based chemotherapy.
Yang Y; Gao W; Ding X; Xu W; Liu D; Su B; Sun Y
Oncotarget; 2017 Mar; 8(10):16313-16324. PubMed ID: 27462918
[TBL] [Abstract][Full Text] [Related]
12. MDM4 rs4245739 A > C polymorphism correlates with reduced overall cancer risk in a meta-analysis of 69477 subjects.
Xu C; Zhu J; Fu W; Liang Z; Song S; Zhao Y; Lyu L; Zhang A; He J; Duan P
Oncotarget; 2016 Nov; 7(44):71718-71726. PubMed ID: 27687591
[TBL] [Abstract][Full Text] [Related]
13. The associations between MDM4 gene polymorphisms and cancer risk.
Wang MJ; Luo YJ; Shi ZY; Xu XL; Yao GL; Liu RP; Zhao H
Oncotarget; 2016 Aug; 7(34):55611-55623. PubMed ID: 27742919
[TBL] [Abstract][Full Text] [Related]
14. An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.
Wynendaele J; Böhnke A; Leucci E; Nielsen SJ; Lambertz I; Hammer S; Sbrzesny N; Kubitza D; Wolf A; Gradhand E; Balschun K; Braicu I; Sehouli J; Darb-Esfahani S; Denkert C; Thomssen C; Hauptmann S; Lund A; Marine JC; Bartel F
Cancer Res; 2010 Dec; 70(23):9641-9. PubMed ID: 21084273
[TBL] [Abstract][Full Text] [Related]
15. ESR1 single nucleotide polymorphism rs1062577 (c.*3804T>A) alters the susceptibility of breast cancer risk in Iranian population.
Dehghan Z; Sadeghi S; Tabatabaeian H; Ghaedi K; Azadeh M; Fazilati M; Bagheri F
Gene; 2017 May; 611():9-14. PubMed ID: 28216037
[TBL] [Abstract][Full Text] [Related]
16. A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer.
Kulkarni DA; Vazquez A; Haffty BG; Bandera EV; Hu W; Sun YY; Toppmeyer DL; Levine AJ; Hirshfield KM
Carcinogenesis; 2009 Nov; 30(11):1910-5. PubMed ID: 19762336
[TBL] [Abstract][Full Text] [Related]
17. The functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma risk.
Fan C; Wei J; Yuan C; Wang X; Jiang C; Zhou C; Yang M
PLoS One; 2014; 9(9):e107047. PubMed ID: 25203442
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis.
Gansmo LB; Lie BA; Mæhlen MT; Vatten L; Romundstad P; Hveem K; Lønning PE; Knappskog S
Gene; 2021 Aug; 793():145747. PubMed ID: 34077778
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of polymorphism rs1563828 in MDM4 gene with breast cancer risk and onset age].
Song CG; Fu FM; Wu XY; Wang C; Shao ZM
Zhonghua Wai Ke Za Zhi; 2012 Jan; 50(1):53-6. PubMed ID: 22490292
[TBL] [Abstract][Full Text] [Related]
20. Profile of the breast cancer susceptibility marker rs4245739 identifies a role for miRNAs.
Anwar SL; Wulaningsih W; Watkins J
Cancer Biol Med; 2017 Nov; 14(4):387-395. PubMed ID: 29372105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]